Effect of Palm Sugar on Blood Glucose Concentrations

Healthy Adults Clinical Trial

— LIPS  

Official title:

Investigation of the Glycaemic Index of Arenga Pinnata Palm Sugar

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01240837
• Other study ID #: 33657
• Status: Completed
• Phase: N/A
• First received: November 11, 2010
• Last updated: March 9, 2012
• Start date: November 2010
• Est. completion date: January 2011

Study information

• Verified date: March 2012
• Source: Wageningen University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine by how much, the ingestion of palm sugar increases blood glucose concentrations and what the corresponding glycaemic index is. The investigators estimate that the glycaemic index will be 68 (equal to that of sucrose).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 21
• Est. completion date: January 2011
• Est. primary completion date: January 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 35 Years

Eligibility

Inclusion criteria:

• Healthy: as judged by the participant;

• Age: 18 to 35.

Exclusion criteria:

• Pregnant or lactating females

• Presence of a chronic disease such as diabetes, illness, dysmetabolic syndrome

• 18.5 < BMI < 25

• Allergy or intolerance to palms or coconuts

• Weight loss or gain of more then 5 kg in the last two months

• Fasting blood glucose levels <100 mg/dl or 5.6 mmol/l

• Smokers

• Use of medications other then birth control

• Previous problems with blood sampling

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Related Conditions & MeSH terms

• Healthy Adults

Intervention

Other:
• Arenga Pinnata Sugar
50 g palm sugar given orally 1 time in 250 ml of water. Blood glucose measurements will then be taken at time points, 0, 15, 30, 45, 60, 90 and 120 minutes.
• Glucose
50 g glucose given orally 3 time in 250 ml of water. Blood glucose measurements will then be taken at time points, 0, 15, 30, 45, 60, 90 and 120 minutes.
• Sucrose
50 g sucrose given orally 1 time in 250 ml of water. Blood glucose measurements will then be taken at time points, 0, 15, 30, 45, 60, 90 and 120 minutes.

Locations

Country	Name	City	State
Netherlands	Wageningen University	Wageningen	Gelderland

Sponsors (1)

Lead Sponsor	Collaborator
Wageningen University

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood glucose concentrations	During the labratory visits subjects will ingest glucose (control), sucrose or palm sugar. At time points 0, 15, 30, 45, 60, 90 and 120 minutes post ingestion blood glucose concentrations will be measured by finger prick blood samples.	2 months	No

External Links

•   Link